Karen Kaucic is senior vice president and global head of PPD® Consulting. In this role, she oversees product development consulting service delivery across all major therapeutic areas including, pre-clinical, clinical, regulatory, CMC and medical device consultancy. She also serves as the global head of PPD's Rare Disease and Pediatric Center of Excellence, which develops and implements next generation strategies to optimize clinical trial delivery in low prevalence indications.
Before joining PPD in 2009, Dr. Kaucic was a senior director in oncology clinical development at MedImmune AstraZeneca. There, she led product development teams for several biologics compounds, including monoclonal antibodies, biospecific antibodies and antibody conjugates.
Earlier in her career, Dr. Kaucic was a staff pediatric oncologist and senior investigator at Children’s National Medical Center in Washington, D.C., where she established the institution’s first hematopoietic stem cell transplantation laboratory, served as an attending physician in oncology and conducted NIH-funded research in signal transduction in human neuroectodermal tumors.
Dr. Kaucic received her medical degree from The Ohio State University followed by a pediatric residency at the same institution. She completed fellowships in pediatric hematology/oncology and transfusion medicine at Children’s National Medical Center and The Cleveland Clinic, respectively. Dr. Kaucic is board certified in pediatric hematology/oncology and holds an active license to practice medicine in the District of Columbia.